Results 11 to 20 of about 3,304 (220)

Retrospective Assessment of Carbonic Anhydrase Inhibitors in Topical or Episcleral Implant Form for the Treatment of Equine Glaucoma. [PDF]

Vet Ophthalmol
ABSTRACT Objective To assess whether topical carbonic anhydrase inhibitors (CAIs) with or without episcleral brinzolamide implants control intraocular pressure (IOP) in horses with glaucoma. Animals Studied 12 client‐owned horses diagnosed with glaucoma.
Tucker-Retter EK, Yamagata M, Gilger B, Oh A.   +3 more
europepmc   +2 more sources

Treatment With Remdesivir Alone or in Combination With GS-441524 in Cats With Ocular Involvement of Feline Infectious Peritonitis: An Observational Case Series. [PDF]

J Vet Intern Med
ABSTRACT Background Remdesivir and GS‐441524 have successfully treated cats with feline infectious peritonitis (FIP) but the changes in associated signs of ocular disease are not reported. Objective Evaluate the response of FIP‐associated signs of ocular disease before and after treatment with remdesivir, GS‐441524, or both.
Andrews ALMM, Izaguirre E, Green J, Scurrell E, Gogova S, Tayler S, Kafarnik C.   +6 more
europepmc   +2 more sources

Effects of brinzolamide on rabbit ocular blood flow in vivo and ex vivo [PDF]

International Journal of Ophthalmology, 2018
AIM: To investigate if significant improvement of optic disc blood flow (ODBF) occurs after instillation of brinzolamide onto rabbit eyes. METHODS: Testing of bilateral intraocular pressure (IOP) and left ODBF in 10 male rabbits took place every 3h over
Ya-Ru Dong, Shi-Wei Huang, Ji-Zhe Cui, Takeshi Yoshitomi   +3 more
doaj   +1 more source

Quantification of Carbonic Anhydrase Inhibitors and Metabolites in Urine and Hair of Patients and Their Relatives

Biology, 2022
Carbonic anhydrase inhibitors (CAIs) are prescription drugs also used in doping to dilute urine samples and tamper with urinalyses. Dorzolamide, brinzolamide, and acetazolamide are prohibited by the World Anti-Doping Agency.
Alfredo Fabrizio Lo Faro, Anastasio Tini, Giulia Bambagiotti, Filippo Pirani, Andrea Faragalli, Flavia Carle, Elena Pacella, Artan Ceka, Marco Moretti, Massimo Gottardi, Nicola Vito Lassandro, Michele Nicolai, Marco Lupidi, Cesare Mariotti, Francesco Paolo Busardò, Jeremy Carlier   +15 more
doaj   +1 more source

Brinzolamide

Reactions Weekly, 2006
europepmc   +2 more sources

Adjunctive antihypertensive therapy of primary glaucoma with a fixed combination drug of 1% brinzolamide and 0.5% timolol: efficacy and safety

Российский офтальмологический журнал, 2023
Purpose: a comparative study of the efficacy and safety of the combination drug Brinzopt Plus and the original drug Azarga used as adjunctive therapy in patients with primary open-angle glaucoma (POAG) previously treated with latanoprost.Material and ...
S. Yu. Petrov, O. M. Kalinina, L. V. Yakubova, S. M. Kosakyan, L. V. Vasilenkova, O. M. Filippova, A. N. Zhuravleva, O. I. Markelova   +7 more
doaj   +1 more source

The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A review [PDF]

, 2017
The acute and chronic effects of repeated intravitreal antivascular endothelial growth factor (VEGF) injections on intraocular pressure have not been fully characterized, and the development of sustained ocular hypertension could adversely affect ...
Bracha, Peter, Cantor, Louis B., Ciulla, Thomas A., Moore, Nicholas A., WuDunn, Darrell   +4 more
core   +1 more source

Two Stability Indicating Chromatographic Methods: TLC Densitometric versus HPLC Method for the Simultaneous Determination of Brinzolamide and Timolol Maleate in Ophthalmic Formulation in the Presence of Probable Carcinogenic Oxidative Degradation Product of Timolol Maleate

Separations, 2023
A comparative study between two stability-indicating chromatographic methods for the assay of brinzolamide and timolol maleate in the co-existence of the probable carcinogenic oxidative degradation product of timolol maleate in their ophthalmic ...
Asmaa A. Mandour, Nada Nabil, Hala E. Zaazaa, Munjed M. Ibrahim, Mohamed A. Ibrahim   +4 more
doaj   +1 more source

24-h Efficacy of Glaucoma Treatment Options [PDF]

, 2016
Current management of glaucoma entails the medical, laser, or surgical reduction of intraocular pressure (IOP) to a predetermined level of target IOP, which is commensurate with either stability or delayed progression of visual loss.
Banu, Bozkurt., Garcia-Feijoo, Julian, Katsanos, Andreas, Konstas, Anastasios, Miglior, Stefano, Pfeiffer, Norbert, Quaranta, Luciano, Rossetti, Luca, Shaarawy, Tarek   +8 more
core   +2 more sources

Papillomacular retinoschisis associated with glaucoma: Response to topical carbonic anhydrase inhibitor

American Journal of Ophthalmology Case Reports, 2020
Purpose: We report the clinical courses of two patients with papillomacular retinoschisis in eyes with advanced glaucomatous optic neuropathy. Observations: In case 1, a 67-year-old woman was diagnosed with papillomacular retinoschisis and normal tension
Masatoshi Haruta, So Handa, Shigeo Yoshida   +2 more
doaj   +1 more source